MARC Record from marc_columbia

LEADER: 05671fam a2200445 a 4500
001 4059551
005 20221027025831.0
008 981105t19991999njua b 001 0 eng c
010 $a 98050919
020 $a0896035239 (alk. paper)
035 $a(OCoLC)40354774
035 $a(OCoLC)ocm40354774
035 $9APD7332HS
035 $a(NNC)4059551
035 $a4059551
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M$dOrLoB-B$dNNC-M
050 00 $aRD652$b.I567 1999
060 10 $aQZ 269$bI63 1999
082 00 $a616.99/40642$221
245 00 $aIntraoperative irradiation :$btechniques and results /$cedited by Leonard L. Gunderson [and others].
260 $aTotowa, N.J. :$bHumana Press,$c[1999], ©1999.
300 $axvii, 550 pages :$billustrations ;$c26 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aCurrent clinical oncology ;$v1
500 $aIncludes bibliographical references and index.
505 00 $gPt. I.$tGeneral Rationale and Historical Perspective.$g1.$tGeneral Rationale and Historical Perspective of Intraoperative Irradiation /$rLeonard L. Gunderson, Felipe A. Calvo and Christopher G. Willett [et al.].$g2.$tBiology of Large Dose per Fraction Radiation Therapy /$rPaul Okunieff, Srinath Sundararaman and Yuhchyaw Chen --$gPt. II.$tMethods and Techniques of Treatment.$g3.$tPhysical Aspects of Intraoperative Electron-Beam Irradiation /$rEdwin C. McCullough and Peter J. Biggs.$g4.$tIOERT Treatment Factors: Technique, Equipment /$rChristopher G. Willett, Leonard L. Gunderson and Paul M. Busse [et al.].$g5.$tPhysics of Intraoperative High-Dose-Rate Brachytherapy /$rLowell L. Anderson, Patrick J. Harrington and Jean St. Germain.$g6.$tHigh-Dose-Rate Intraoperative Irradiation (HDR-IORT): Technical Factors /$rLouis B. Harrison, Alfred M. Cohen and Warren E. Enker.
505 80 $g7.$tIntraoperative Irradiation with Electron-Beam or High-Dose-Rate Brachytherapy: Methodological Comparisons /$rSubir Nag, Leonard L. Gunderson and Christopher G. Willett [et al.] --$gPt. III.$tNormal Tissue Tolerance - IORT.$g8.$tNormal Tissue Tolerance to Intraoperative Irradiation: The National Cancer Institute Experimental Studies /$rWilliam F. Sindelar, Peter A. S. Johnstone and Harald J. Hoekstra [et al.].$g9.$tStudies at Colorado State University of Normal Tissue Tolerance of Beagles to IOERT, EBRT, or a Combination /$rEdward L. Gillette, Sharon M. Gillette and Barbara E. Powers.$g10.$tPeripheral Nerve Tolerance: Experimental and Clinical /$rEdward Gillette, Barbara E. Powers and Sharon M. Gillette [et al.] --$gPt. IV.$tResults of IORT With or Without EBRT by Disease Site.$g11.$tGastric IORT With or Without EBRT /$rRafael Martinez-Monge, Jean P. Gerard and H. J. Kramling [et al.].$g12.$tIORT in Pancreatic Carcinoma /$rPaula M. Termuhlen, Douglas B. Evans and Christopher G. Willett.
505 80 $g13.$tBiliary Tract IORT: Bile Duct and Gallbladder /$rTakeshi Todoroki, Leonard L. Gunderson and David Nagorney.$g14.$tPrimary Colorectal EBRT and IOERT /$rChristopher G. Willett, Paul C. Shellito and Leonard L. Gunderson.$g15.$tRecurrent Colorectal: EBRT With or Without IOERT or HDR-IORT /$rLeonard L. Gunderson, Christopher G. Willett and Michael G. Haddock [et al.].$g16.$tHDR-IORT for Colorectal Cancer: Clinical Experience /$rLouis B. Harrison, Bruce D. Minsky and Carol White [et al.].$g17.$tRadiation Ablation of Liver Metastases: HDR-IORT With or Without EBRT /$rCatherine L. Salem and Anatoly Dritschilo.$g18.$tElectron or Orthovoltage IORT for Retroperitoneal Sarcomas /$rHolger L. Gieschen, Christopher G. Willett and John Donohue [et al.].$g19.$tHDR-IORT for Retroperitoneal Sarcomas /$rLouis B. Harrison, Lowell Anderson and Carol White [et al.].$g20.$tExtremity and Trunk Soft Tissue Sarcomas: EBRT With or Without IORT /$rIvy A. Petersen, Felipe A. Calvo and Leonard L. Gunderson [et al.].
505 80 $g21.$tIORT for Bone Sarcomas /$rFelipe A. Calvo, Luis Sierrasesumaga and Norman Willich [et al.].$g22.$tLocally Advanced Primary and Recurrent Gynecologic Malignancies: EBRT With or Without IOERT or HDR-IORT /$rMichael G. Haddock, Rafael Martinez-Monge and Ivy A. Petersen [et al.].$g23.$tGenitourinary IORT /$rFelipe A. Calvo, Horst Zincke and Leonard L. Gunderson [et al.].$g24.$tLung Cancer: EBRT With or Without IORT /$rJavier Aristu, Felipe A. Calvo and Rafael Martinez [et al.].$g25.$tPediatric Malignancies: IORT Alone or With EBRT /$rPaula J. Schomberg, Thomas E. Merchant and Gerald Haase [et al.].$g26.$tIORT for Head and Neck Cancer /$rRobert L. Foote, Peter Garrett and William Rate [et al.].$g27.$tIORT for CNS Tumors /$rD. Ortiz de Urbina, N. Willich and R. R. Dobelbower [et al.].$g28.$tIORT for Breast Cancer /$rJoyce A. Battle, Jean-Bernard DuBois and Hollis W. Merrick [et al.] --$gPt. V.$tConclusions and Future Possibilities.
505 80 $g29.$tConclusions and Future Possibilities - IORT /$rLeonard L. Gunderson, Christopher G. Willett and Felipe A. Calvo [et al.].
650 0 $aCancer$xIntraoperative radiotherapy.$0http://id.loc.gov/authorities/subjects/sh88007549
650 12 $aNeoplasms$xradiotherapy.$0https://id.nlm.nih.gov/mesh/D009369Q000532
650 22 $aIntraoperative Care$xmethods.$0https://id.nlm.nih.gov/mesh/D007430Q000379
650 22 $aBrachytherapy$xmethods.$0https://id.nlm.nih.gov/mesh/D001918Q000379
650 22 $aRadiotherapy Dosage.$0https://id.nlm.nih.gov/mesh/D011879
650 22 $aElectrons$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D004583Q000627
700 1 $aGunderson, Leonard L.$0http://id.loc.gov/authorities/names/n99801278
830 0 $aCurrent clinical oncology ;$vv. 1.
852 00 $boff,hsl$hRD652$i.I567 1999